<DOC>
	<DOCNO>NCT00731055</DOCNO>
	<brief_summary>The investigator hypothesize varenicline dose dependently attenuate subjective effect cigarettes period abstinence . Also , treatment varenicline dose dependently weaken severity nicotine withdrawal symptom . Thirdly , hypothesize treatment varenicline dose dependently decrease cigarette self-administration model propose .</brief_summary>
	<brief_title>Effects Varenicline Cigarette Self Administration</brief_title>
	<detailed_description>Tobacco use lead preventable cause death U.S.A. Every year 400,000 people die cigarette smoking 2006 , one every five death US smoke relate . Recent advance laboratory study tobacco effect human understanding effect nicotine brain behavior present opportunity advance medication development . The addictive property nicotine think result nicotine trigger acute release dopamine , pleasurable event person seek repeat . Varenicline partial agonist nicotine receptor , therefore also trigger release dopamine sustain moderate manner , could counter low dopamine level arise lack nicotine therefore aid craving . Also , bind nicotine receptor advance smoking , could stop nicotine bind create pleasurable effect . This study assess effect acute treatment varenicline placebo early tobacco withdrawal , acute effect cigarettes cigarette self-administration cigarette-smoking volunteer . After overnight abstinence , participant come lab receive acute treatment vary dos varenicline placebo perform computer test fill questionnaire . Then give opportunity smoke operational condition ( cigarette versus money choice ) . This study employ within-group , double-blind , randomize counterbalanced design . The main goal project improve current laboratory model smoke cessation study mechanism involve smoking maintenance . We hypothesize varenicline dose-dependently : 1 ) decrease nicotine withdrawal symptom , 2 ) decrease acute effect cigarettes 3 ) decrease self-administration cigarette laboratory paradigm . Showing effectiveness varenicline propose laboratory model confirm model 's predictive validity detect clinically effective medication .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . A diagnosis nicotine dependence physiological dependence , smoke least 15 cigarettes/day last 3 month . 2 . Not interested treatment 3 . Medically healthy basis physical examination medical history , vital sign , EKG laboratory test , negative pregnancy test female . 4 . Able perform study procedures 5 . Males female age 2145 yr 6 . Female participant agree use effective method birth control course study 1 . A diagnosis abuse dependence alcohol drug nicotine 2 . Current Axis I diagnosis current treatment psychotropic medication ( within last 3 month ) 3 . Lifetime history schizophrenia psychotic disorder , bipolar disorder , anxiety disorder 4 . Currently seek treatment nicotine dependence 5 . Participants parole probation 6 . History significant recent violent behavior 7 . Blood pressure &gt; 150/90 8 . History allergic reaction study medication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>